- Home
- GSK vs ROP Comparison
GSK vs ROP Comparison
Compare GSK & ROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- ROP
- Stock Information
- Founded
- GSK 1715
- ROP 1981
- Country
- GSK United Kingdom
- ROP United States
- Employees
- GSK N/A
- ROP N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- ROP Industrial Machinery/Components
- Sector
- GSK Health Care
- ROP Industrials
- Exchange
- GSK Nasdaq
- ROP Nasdaq
- Market Cap
- GSK 74.6B
- ROP 61.7B
- IPO Year
- GSK N/A
- ROP 1992
- Fundamental
- Price
- GSK $36.64
- ROP $574.05
- Analyst Decision
- GSK Hold
- ROP Buy
- Analyst Count
- GSK 4
- ROP 11
- Target Price
- GSK $47.00
- ROP $622.30
- AVG Volume (30 Days)
- GSK 5.2M
- ROP 617.2K
- Earning Date
- GSK 02-05-2025
- ROP 01-30-2025
- Dividend Yield
- GSK 4.21%
- ROP 0.57%
- EPS Growth
- GSK N/A
- ROP 11.35
- EPS
- GSK 0.78
- ROP 14.35
- Revenue
- GSK $39,280,393,592.00
- ROP $7,039,200,000.00
- Revenue This Year
- GSK $6.43
- ROP $10.99
- Revenue Next Year
- GSK $5.34
- ROP $7.33
- P/E Ratio
- GSK $23.15
- ROP $40.00
- Revenue Growth
- GSK 3.46
- ROP 13.94
- 52 Week Low
- GSK $31.72
- ROP $499.47
- 52 Week High
- GSK $45.93
- ROP $584.43
- Technical
- Relative Strength Index (RSI)
- GSK 58.60
- ROP 58.79
- Support Level
- GSK $36.35
- ROP $568.14
- Resistance Level
- GSK $37.22
- ROP $581.88
- Average True Range (ATR)
- GSK 0.62
- ROP 8.92
- MACD
- GSK 0.04
- ROP -0.75
- Stochastic Oscillator
- GSK 65.58
- ROP 45.80
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About ROP Roper Technologies Inc.
Roper Technologies is a diversified technology company that operates three segments: application software, network software, and technology enabled products. Roper acquires asset light, cash generative businesses and deploys excess cash to acquire further portfolio companies. The firm operates a highly decentralized model with portfolio company management holding autonomy and accountability for key operational decisions, and a small, centralized team overseeing capital deployment and providing executive coaching and reviewing strategic goals.